ERIC KOO, MBA, B. Pharm

ERIC KOO, MBA, B. Pharm, serves as CEO at Overland ADCT Biopharmaceuticals.

Prior to Overland ADCT, Eric was Vice President, Head of Oncology Business Unit at Takeda China focusing on multiple myeloma and lymphoma. Prior to joining Takeda, Eric served as Director, Oncology Business Unit and Director, Market Access, External Affairs & Key Account Management at Merck, Sharp and Dome (MSD) Taiwan. Prior to MSD, he served as Regional Marketing Director for APAC & Specialty Care BU Head, Malaysia/Singapore at Bayer APAC. Mr. Koo started his pharmaceutical career at Pfizer, spending 16 years in various sales, product management and marketing positions at both Pfizer Taiwan and Pfizer Emerging Market Asia & China, including 5 years as the China/APAC Regional Marketing Director for Oncology.

Mr. Koo earned his B. Pharmacy from Taipei Medical University and MBA from the University of North Carolina at Charlotte, Belk College of Business.